Insulin aspart Sanofi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Insulin aspart Sanofi, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: EMA Authorised: Insulin aspart Sanofi (insulin aspart) — Sanofi Winthrop Industrie